Details for New Drug Application (NDA): 019058
✉ Email this page to a colleague
The generic ingredient in TENORMIN is atenolol. There are thirty-four drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the atenolol profile page.
Summary for 019058
Tradename: | TENORMIN |
Applicant: | Astrazeneca |
Ingredient: | atenolol |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 019058
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 0.5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Sep 13, 1989 | TE: | RLD: | Yes |
Complete Access Available with Subscription